Interview: Hemogenyx

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

Author: Zak Mir

Financial commentator, interviewer, technical analyst

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s